Yang Liu

WORK HISTORY

EDUCATION

ABOUT YANG LIU

With our specialist immune capture ELISA systems, we provide Best-in-Class ELISA kits. We are a Germany-based biotechnology company located in Hamburg that focuses on providing top-quality tests for tropical and emerging infectious diseases. ‍ Leveraging our patented technology platform, our immunoassay tests have superior specificity and sensitivity, especially targeting the priority diseases in the WHO blueprint list. The outstanding performance characteristics of our tests have proven that we are providing the best tools for scientists, researchers, and health authorities for their tasks of outbreak monitoring, infection surveillance, and seroprevalence studies. With our patented technologies, surfaces coated with specialized membrane Fc-receptor molecules are used to capture immune complexes formed in vitro. The technologies allow for flexibility in assay design to detect either IgG or IgM antibodies in human or animal sera and enable high specificity and sensitivity through the immune complex detection mechanism. Our patented membrane receptor-based assay platform empowers the serological assays with superior sensitivity and specificity. Our optimized antigens ensure preservation of conformational epitopes and reduce non-specific binding Our competitor approach efficiently further suppresses false positive signals, giving more accurate results. We provide serological ELISA kits for research and surveillance of tropical and emerging infectious diseases on the WHO Blueprint List of Priority Diseases, such as CCHFV, ZIKV, and LASV, covering IgG and IgM detection.